LPT-723 AND IMMUNE CHECKPOINT INHIBITOR COMBINATIONS AND METHODS OF TREATMENT

or a pharmaceutically acceptable salt thereof, optionally, in combination with at least one immune checkpoint inhibitor compound. Kits containing the composition, and methods of using the composition for ameliorating or treating the effects of a disease such as a cancer, in a subject, are also provi...

Full description

Saved in:
Bibliographic Details
Main Authors Zhang, Xiaoyan Michelle, Saha, Saurabh, Zhang, Linping
Format Patent
LanguageEnglish
Published 15.10.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:or a pharmaceutically acceptable salt thereof, optionally, in combination with at least one immune checkpoint inhibitor compound. Kits containing the composition, and methods of using the composition for ameliorating or treating the effects of a disease such as a cancer, in a subject, are also provided herein.
Bibliography:Application Number: US202016915562